Thyroid Clinical Trial
Official title:
IMRT Followed by Pembrolizumab in the Adjuvant Setting in Anaplastic Cancer of the Thyroid (IMPAACT): Phase II Trial Adjuvant Pembrolizumab After IMRT in ATC
This is an open label, single center, phase 2 trial of adjuvant pembrolizumab after external beam radiation to the primary tumor in patients with stage IVB (disease localized to the neck) ATC. This drug trial will estimate the median progression-free survival (PFS) (from the start of adjuvant pembrolizumab until locoregional progression, development of distant metastatic disease, or death) in stage IVB ATC patients with gross disease, treated with external beam radiation (+/- concomitant chemotherapy) followed by adjuvant pembrolizumab. Patients will be patients enrolled from cohort 1 and 2 (cohort 1: ≥51 Gy; cohort 2: ≤50 Gy).
Primary Objective: -To estimate the median progression-free survival (PFS) (from the start of adjuvant pembrolizumab until locoregional progression, development of distant metastatic disease, or death) in stage IVB ATC patients with gross disease, treated with external beam radiation (+/- concomitant chemotherapy) followed by adjuvant pembrolizumab. Patients will be patients enrolled from cohort 1 and 2 (cohort 1: ≥51 Gy; cohort 2: ≤50 Gy). Secondary Objective: -To estimate median overall survival in stage IVB ATC patients treated with external beam radiation (+/- concurrent chemotherapy) followed by adjuvant pembrolizumab. Patients will be stratified by dose of external beam radiation. Exploratory Objective: -To estimate the median disease-free survival (DFS) in patients with stage IVB ATC treated with surgery/external beam radiation/concomitant chemotherapy followed by adjuvant pembrolizumab (cohort 3). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04085913 -
Exparel Injection Effect on Postoperative Opioid Usage
|
Early Phase 1 | |
Completed |
NCT04647006 -
Comparison of TOETVA and Conventional Thyroidectomy
|
N/A | |
Completed |
NCT04763122 -
Thyroid Cancer in United Arab Emirates
|
||
Completed |
NCT05323539 -
Comparison of Thyroid Volumes in Patients With and Without Endometrioma
|
N/A | |
Recruiting |
NCT04160637 -
Is There Benefit From Early Postoperative PTH Monitoring?
|
||
Completed |
NCT03597659 -
PheWAS of a Polygenic Predictor of Thyroid Function
|
||
Completed |
NCT03430141 -
A Nutritarian Study to Evaluate the Effectiveness of Lifestyle Changes in Chronic Disease Prevention, Especially Cancer
|
N/A | |
Recruiting |
NCT04115514 -
Treatment of ARDS With Instilled T3
|
Phase 2 | |
Recruiting |
NCT04623801 -
Laser Ablation of Papillary Thyroid Microcarcinoma
|
Phase 2 | |
Recruiting |
NCT03754621 -
Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey
|
||
Withdrawn |
NCT03060499 -
Post Thyroidectomy Myocardial Function
|
||
Completed |
NCT05276271 -
The Effect of Levetiracetam on Lipid Profile in Children
|
||
Recruiting |
NCT04014660 -
Prevention av Autoimmunitet Med Laktobaciller
|
N/A | |
Completed |
NCT02304172 -
The Efficacy and Safety of Thunderbeat in Thyroid Surgery
|
N/A | |
Recruiting |
NCT04571736 -
Pilot Study for Thyroid Surgery by Preoperative Video Support and Personalized and Secure Web Platform
|
N/A | |
Recruiting |
NCT05510609 -
Three-dimensional Ultrasonography Thyroid Volume Measurement.
|
N/A | |
Active, not recruiting |
NCT05328076 -
Parathyroid Vascularization During Total Thyroidectomy Using Indocyanine Green Angiography
|
||
Not yet recruiting |
NCT06377943 -
The Interaction Between Resting Metabolic Rate, Physical Activity and Thyroid Hormone in Females
|
||
Recruiting |
NCT03933358 -
Effect of Thyroid Hormone on Post-Myocardial Infarction Remodeling and Prognosis in STEMI Patients
|
||
Active, not recruiting |
NCT02681328 -
Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules
|